Massive study aims to tame pregnancy diabetes risks

NCT ID NCT07161947

Recruiting now Knowledge-focused Sponsor: Shanghai General Hospital, China Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study will follow 4,000 pregnant women with high blood sugar (gestational diabetes or pre-existing diabetes) to create better standards for diagnosis, treatment, and follow-up. Researchers will track health problems in mothers and babies, like preeclampsia or preterm birth, and check blood sugar levels after delivery. The goal is to improve care from before pregnancy through the postpartum period.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better care guidelines for managing high blood sugar during and after pregnancy, reducing health risks for mothers and babies.
What could go wrong: This is an observational study, not a treatment trial. It may not directly change outcomes, and results depend on accurate data collection from medical records.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GESTATIAONL DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gestational diabetes

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GESTATIAONL DIABETES MELLITUS HYPERGLYCEMIA IN PREGNANT DIABETIC PATIENTS

Contacts and locations

Locations

Shanghai General Hospital, China
RECRUITING

Shanghai, Shanghai Municipality, 200080, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.